Meta-analysis of TKI combinations in glioblastoma shows improved PFS and ORR with mixed safety signals
New Hope for Glioblastoma Patients Emerges
This meta-analysis evaluated combination treatments incorporating tyrosine kinase inhibitors (TKIs) versus TKI-free control regimens in 1,43…
Imagine getting the hardest diagnosis a person can hear: a fast-growing brain tumor with few good treatment options.
GSC-associated gene signature predicts survival in adult and pediatric high-grade glioma patients
New Brain Tumor Test Predicts Survival More Accurately
This cohort study evaluated a GSC-associated gene signature involving the FAM86B1/FAM86B2 axis in adult and pediatric high-grade glioma pati…
A new model uses specific genes to predict how long patients might live with aggressive brain tumors.
Unsupervised clustering of glioma RNAseq data shows diagnostic and prognostic potential
AI-powered analysis reveals hidden brain tumor subtypes with survival links
This unsupervised clustering analysis of public TCGA glioma RNAseq data (n=692) found high diagnostic concordance and prognostic separation.
A new AI method sorted brain tumors into groups that matched clinical diagnoses 91% of the time and uncovered subtypes tied to survival.
ERS-related DNA methylation profiles stratify glioblastoma patients into four subtypes with 92.4% prediction accuracy
New AI Tool Could Help Doctors Choose Better Brain Tumor Treatments
This cohort analysis of a TCGA glioblastoma population integrated ERS-related DNA methylation profiles with non-negative matrix factorizatio…
Scientists used AI to find hidden patterns in brain tumors that could lead to better treatment plans.
Narrative review on ferroptosis-targeting strategies for glioblastoma modulation
New Brain Tumor Strategy Targets Iron to Boost Immune Attack
This narrative review synthesizes mechanisms and strategies for targeting ferroptosis in glioblastoma.
This new approach uses the tumor's own iron problem to help the body's immune system destroy cancer cells more effectively.
Systematic review evaluates Treg depletion and reprogramming strategies for glioblastoma in adults
A New Tactic to Outsmart the Brain’s Most Aggressive Cancer
This systematic review examined interventions targeting regulatory T cells in adults with glioblastoma.
Researchers are designing new weapons that could help a patient’s own immune system finally attack a deadly brain tumor.
Phase 1/2 trial shows RT + bevacizumab + olaptesed pegol extends PFS and OS in unmethylated GBM
New Drug Combo Slows Brain Cancer Growth
A Phase 1/2 expansion arm in six patients with newly-diagnosed, unmethylated GBM found that adding bevacizumab to radiotherapy and olaptesed…
Adding a second drug to stop blood vessel growth gives patients with brain cancer more time before the disease returns.
DOC1021 vaccine with SOC showed favorable 12-month OS in newly-diagnosed glioblastoma patients
A New Brain Cancer Vaccine Shows Promise Where Other Treatments Fail
This Phase I clinical study evaluated DOC1021 (dubodencel) integrated with standard of care (SOC) in newly-diagnosed and recurrent glioblast…
A new type of personalized vaccine, added to standard treatment, was safe and linked to significantly longer survival for patients with a no…
Multi-omics integration identifies candidate genes and cell-type-specific effects in glioma
Could genetic clues finally pinpoint the right cells to target in deadly brain tumors?
This computational analysis integrated GWAS, bulk tissue, and single-cell multi-omics data to investigate glioma.
A new analysis of genetic maps shows deadly brain tumors drive growth by increasing communication between support cells and nerve cells.
PARPi combinations show no significant clinical improvement in adult patients with glioblastoma
PARPi drugs show limited benefit for glioblastoma due to brain barriers
This systematic review evaluated poly-ADP-ribose polymerase inhibitors (PARPi) combined with standard therapy for adult patients with gliobl…
A systematic review examined PARP inhibitors used with standard treatments for adult glioblastoma patients.
Deep learning QTMnet shows potential for glioma grading versus traditional 2CXM model
AI method shows promise for classifying brain tumor severity in small study
A study of 30 glioma patients compared a deep neural network-based perfusion estimation method (QTMnet) to a traditional two-compartment exc…
New AI analysis of brain scans outperformed traditional methods at telling the difference between low and high severity tumors in a small te…
Research across Glioma
Related studies from across the Glioma family.
Meta-analysis of bevacizumab therapy in recurrent glioblastoma multiforme shows associations with improved outcomes
Bevacizumab therapy linked to better survival and fewer bleeding risks in recurrent brain cancer
This meta-analysis evaluates bevacizumab (BEV) therapy, temozolomide (TMZ), and lomustine in patients with recurrent glioblastoma multiforme…
A large review of patients with recurrent brain cancer found bevacizumab therapy linked to better survival and fewer bleeding risks compared…
PINK1 expression quantified by IHC in adults with newly diagnosed IDH-wild type glioblastoma multiforme
A Simple Brain Tumor Test Could Predict Your Treatment Path
This prospective observational cohort study evaluated PINK1 expression in adults (18+ years) with newly diagnosed IDH-wild type glioblastoma…
A specific protein in glioblastoma tissue could forecast survival odds, helping patients plan care even though the test is not available yet…
Questions about Glioblastoma
Can focused ultrasound gene therapy improve outcomes for glioblastoma based on preclinical studies?
Yes, preclinical studies show focused ultrasound gene therapy significantly enhances gene expression, reduces tumor volume, and improves survival in glioblastoma animal models.
Full answer →Did adding tumor treating fields to chemotherapy help newly diagnosed glioblastoma patients live longer?
Yes, adding tumor treating fields (TTFields) to chemotherapy significantly improved overall survival and progression-free survival in newly diagnosed glioblastoma patients, according to a meta-analysis and clinical studies.
Full answer →